Skip to content

Calculus invests £1m into Wazoku

Calculus Capital has invested £1m in Wazoku Limited, a fast-growing software-as-a-service (SaaS) business providing market-leading innovation management software to enterprise customers including John Lewis, HSBC and the Ministry of Defence. Wazoku’s mission is to enable companies to embed innovation as a core, strategic, everyday capability. Successful innovation requires not only capturing raw ideas, but also … Continued

Every1Mobile: Supporting Businesses and Communities Through Mobile Technology is Vital to Combat COVID-19

COVID-19 has increased the urgency for reliable, accessible and regular health information, and forced a shift to remote community engagement and greater focus on local-led responses. Every1Mobile’s experience in Kenya shows that capacity building and mobilisation of local informal businesses through digital technology can empower high-risk communities with knowledge to combat COVID-19 and reduce financial barriers … Continued

Scancell’s vaccine technology featured on Sky News

The government is putting big bets on vaccines that may not work against the coronavirus, scientists have warned. Around 90% of experimental vaccines never reach the clinic because of problems in development or manufacture.But the government’s Vaccines Taskforce has invested more than £100m in COVID-19 vaccines being developed at Oxford University and Imperial College London. A … Continued

Open Orphan Launch Covid-19 Antibody Testing

LONDON, June 4, 2020 /PRNewswire/ — Launched on Thursday 4th June 2020, hVIVO COVID Clear Test,, which is part of Open Orphan plc,, is the most accurate antibody test available to UK employers, helping them to get their people back to work. Having recently secured the rights from Quotient for their antibody testing platform which detects with 100% accuracy antibodies … Continued

Genedrive’s David Budd details launch of its unique COVID-19 test kits

Genedrive CEO David Budd details launch of its unique coronavirus test kits and plans for first sale, in an interview for Proactive Investors. The first, which was CE marked last week, is a high-throughput lab-based PCR test which assesses whether someone has an active infection. Genedrive’s PCR bead format eliminates the need for the time … Continued